INTERNATIONAL PATENT: ORIC PHARMACEUTICALS, INC. FILES APPLICATION FOR "CIP2A RNA SPLICE MODIFIERS FOR USE IN TREATMENT OF CANCER"

GENEVA, Dec. 24 -- ORIC PHARMACEUTICALS, INC. (240 East Grand Avenue, #2South San Francisco, California 94080) filed a patent application (PCT/US2025/033387) for "CIP2A RNA SPLICE MODIFIERS FOR USE IN TREATMENT OF CANCER" on Jun 12, 2025. With publication no. WO/2025/259899, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ROMERO, F. Anthony (240 East Grand Avenue, #2South San Francisco, California 94080), ROBERTS, Tucker Curran (240 East Grand Avenue, #2South San Francisco, California 94080), BLANK, Brian R. (240 East Gra...